Patent classifications
A61K8/675
Eutectic mixtures in personal care compositions
The invention relates to active eutectic mixtures of butyl methoxydibenzoylmethane, isopropyl myristate and optionally 12-hydroxystearic acid, personal care products comprising such active eutectic mixtures, a method for preparing such personal care compositions and a method of applying to human skin such personal care compositions.
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
SILICONE ELASTOMER IN OILY PHASE
The present invention relates to a composition, in particular a cosmetic composition, comprising a physiologically acceptable medium containing at least one oily phase, said oily phase comprising: (i) at least one silicone elastomer present within water droplets dispersed in said oily phase; and (ii) at least one polyglycerylated silicone surfactant with an HLB greater than or equal to 8.
ANTI-AGING AGENT AND ANTI-AGING METHOD
PROBLEM: To provide an anti-aging agent and a method for the anti-aging that are safe in long-term intake and ensures effective suppression of the progress of the aging.
SOLUTION: Nicotinamide mononucleotide is contained as an active ingredient.
SOAP BASED SUNSCREEN COMPOSITION
The present invention relates to a composition comprising: a) one or more fatty acids selected from the group consisting of straight or branched saturated fatty acids in C.sub.8-C.sub.30, b) at least one basic agent, c) at least one lipophilic UV absorption agent, d) at least hydrophobic silica aerogel particles, and e) at least one aqueous phase.
Method of identifying or evaluating synergistic combinations of actives and compositions containing the same
A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.
SKIN LIGHTENING COMPOSTIONS
Disclosed are compositions and methods for their use that include a combination of Leontopodium alpinum extract, Halidrys siliquosa extract, vegetable amino acids, niacinamide, hexylresorcinol, Pinus pinaster extract, Betula alba extract, Albizia julibrissin bark extract, hydrolyzed Candida saitoana extract, Lentinus edodes mycelium extract, and/or Opuntia tuna fruit extract.
Cosmetic compositions and methods for inhibiting melanin synthesis
A cosmetic composition suitable for topical application, for example, is provided. In some examples, the cosmetic composition may include bisabolol, undecylenoyl phenylalanine and/or hexyldecanol, and a material selected from the group consisting of ethyl palmitate, stearyl alcohol, bis (2-ethylhexyl) adipate, bis (2-ethylhexyl) maleate, 5-pentadecanol, 1-stearoyl-rac-glycerol, bis (2-ethylhexyl) sebacate, and mixtures thereof. A method of reducing the synthesis of melanin by using the cosmetic compositions is also disclosed herein.
Mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)
The present invention relates to a modified-release composition of mazindol and its use in the treatment of attention deficit disorders (ADD) or attention deficit/hyperactivity disorder (ADHD) or related deficit of alertness (i.e., incoercible sleepiness) or decline of vigilance (i.e., daytime somnolence) or excessive daytime sleepiness (e.g., narcolepsy, idiopathic hypersomnia) in particular in children, adolescents and adults.
EXTEMPORANEOUS COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS
The present invention relates to an extemporaneous product for the preparation of dermatological and/or cosmetic compositions, this product comprising, on the one hand, one or several active substances and on the other, a universal base allowing such active substance or substances to be solubilised and comprising at least one oil rich in omega-3, water, glycerine, an alcohol other than glycerine, and emulsifier and a biomimetic peptide.